COVID-19 endocrinopathy with hindsight from SARS

Kothandaraman Narasimhan, Rengaraj Anantharaj, Bo Xue, Wen Shan Yew, S. Sendhil Velan, Neerja Karnani, Melvin Khee‐Shing LeowAmerican 2020 · DOI

Abstract

The current COVID-19 pandemic is probably the worst the world has ever faced since the start of the new millennium. Although the respiratory system is the most prominent target of SARS-CoV-2 (the contagion of COVID-19), extrapulmonary involvement are emerging as important contributors of its morbidity and lethality. This article summarizes the impact of SARS-CoV and SARS-CoV-2 on the endocrine system to facilitate our understanding of the nature of coronavirus-associated endocrinopathy. Although new data are rapidly accumulating on this novel infection, many of the endocrine manifestations of COVID-19 remain incompletely elucidated. We, hereby, summarize various endocrine dysfunctions including coronavirus-induced new onset diabetes mellitus, hypocortisolism, thyroid hormone, and reproductive system aberrations so that clinicians armed with such insights can potentially benefit patients with COVID-19 at the bedside.
BibTeX
@inproceedings{narasimhan2020covid,
  author = {Kothandaraman Narasimhan and Rengaraj Anantharaj and Bo Xue and Wen Shan Yew and S. Sendhil Velan and Neerja Karnani and Melvin Khee‐Shing Leow},
  title = {{COVID-19 endocrinopathy with hindsight from SARS}},
  booktitle = {American},
  year = {2020},
  doi = {10.1152/ajpendo.00480.2020},
}

Loading related content...

Figure